Sulfonamides Residue (SAs) (6-atom-rings) antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Sulfonamides Residue (SAs) (6-atom-rings) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-2-1 | 1. BSA-Sulfonamides Residue (SAs) (6-atom-rings) 2. Anti-Sulfonamides Residue (SAs) (6-atom-rings) mouse monoclonal antibody | $2709.00 |
GMP-SMT-2-2 | 1. OVA-Sulfonamides Residue (SAs) (6-atom-rings) 2. Anti-Sulfonamides Residue (SAs) (6-atom-rings) mouse monoclonal antibody | $2709.00 |
GMP-SMT-2-3 | 1. BSA-Sulfonamides Residue (SAs) (6-atom-rings) 2. Anti-Sulfonamides Residue (SAs) (6-atom-rings) human monoclonal antibody | $2709.00 |
GMP-SMT-2-4 | 1. OVA-Sulfonamides Residue (SAs) (6-atom-rings) 2. Anti-Sulfonamides Residue (SAs) (6-atom-rings) human monoclonal antibody | $2709.00 |
GMP-SMT-2-Ag-1 | BSA-Sulfonamides Residue (SAs) (6-atom-rings) | $756.00 |
GMP-SMT-2-Ag-2 | OVA-Sulfonamides Residue (SAs) (6-atom-rings) | $756.00 |
GMP-SMT-2-Ab-1 | Anti-Sulfonamides Residue (SAs) (6-atom-rings) mouse monoclonal antibody | $1953.00 |
GMP-SMT-2-Ab-2 | Anti-Sulfonamides Residue (SAs) (6-atom-rings) human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Sulfonamides Residue (SAs) (6-atom-rings)
Cat No. | GMP-SMT-2-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Sulfonamides Residue (SAs) (6-atom-rings) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Sulfonamides Residue (SAs) (6-atom-rings) had been validated with our anti-Hapten antibody Anti-Sulfonamides Residue (SAs) (6-atom-rings) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Sulfonamides Residue (SAs) (6-atom-rings)
Cat No. | GMP-SMT-2-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Sulfonamides Residue (SAs) (6-atom-rings) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Sulfonamides Residue (SAs) (6-atom-rings) had been validated with our anti-Hapten antibody Anti-Sulfonamides Residue (SAs) (6-atom-rings) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Sulfonamides Residue (SAs) (6-atom-rings) mouse monoclonal antibody
Cat No. | GMP-SMT-2-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 2-5 |
Products description | The anti-Hapten antibody against hapten Sulfonamides Residue (SAs) (6-atom-rings) had been validated with our hapten hapten-carrier conjugates BSA-Sulfonamides Residue (SAs) (6-atom-rings) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Sulfonamides Residue (SAs) (6-atom-rings) human monoclonal antibody
Cat No. | GMP-SMT-2-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 2-5 |
Products description | The anti-Hapten antibody against hapten Sulfonamides Residue (SAs) (6-atom-rings) had been validated with our hapten hapten-carrier conjugates BSA-Sulfonamides Residue (SAs) (6-atom-rings) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
3. Sulfonamides Residue (SAs) in Veterinary Drug Residues and Additives:
Sulfonamides Residue, often abbreviated as SAs, refers to a specific class of chemical compounds that play a pivotal role in the field of veterinary medicine. Characterized by their distinctive six-atom ring structure, Sulfonamides are potent antimicrobial agents that are widely employed in the treatment and prevention of bacterial infections in animals. These compounds have proven instrumental in improving animal health and welfare, contributing to increased livestock productivity and the well-being of companion animals (1).
Despite their significant benefits, the use of Sulfonamides in veterinary medicine also gives rise to concerns about the persistence of residues in animal tissues. These residues can pose potential risks to food safety and human health if not carefully managed. To address these concerns, regulatory bodies around the world establish Maximum Residue Limits (MRLs) for Sulfonamides in animal-derived products. These MRLs serve as critical safeguards to ensure that the levels of Sulfonamides in consumable goods remain within safe and acceptable limits (2).
Ensuring compliance with these MRLs requires precise and reliable measurement techniques. This is where innovative solutions come into play. Our biopharmaceutical company is at the forefront of providing cutting-edge solutions designed to enable the accurate detection and quantification of Sulfonamides Residue in animal-derived products. We offer a range of advanced tools, including anti-Sulfonamides antibodies and small molecules competitive antigens, which are instrumental in ensuring the safety and quality of consumable goods (3).
4. The Importance of Measuring Sulfonamides Residue:
The measurement of Sulfonamides Residue is of paramount importance for several critical reasons, each of which contributes to the overall well-being of both animals and humans. These reasons encompass food safety, regulatory compliance, and the mitigation of antibiotic resistance.
First and foremost, precise quantification of Sulfonamides Residue is essential to guarantee the safety of the food supply. When Sulfonamides are administered to animals, they can leave residues in their tissues, including meat and dairy products. If these residues exceed established MRLs, they can pose health hazards to consumers. Therefore, rigorous monitoring and control of Sulfonamides Residue levels are essential to protect public health (5).
Furthermore, accurate measurement of Sulfonamides Residue plays a crucial role in the ongoing battle against antibiotic resistance. The overuse and misuse of antibiotics, including Sulfonamides, can contribute to the development of antibiotic-resistant bacteria. By monitoring and quantifying Sulfonamides Residue, it becomes possible to assess the potential contribution of these compounds to the development of antibiotic resistance. This aligns with the global effort to encourage responsible and judicious antimicrobial usage, helping to preserve the efficacy of these vital drugs for both animal and human medicine (6).
Our company's commitment to providing advanced testing components, such as anti-Sulfonamides antibodies and small molecules competitive antigens, contributes significantly to the industry's ability to achieve meticulous quality control. This, in turn, upholds consumer trust and supports scientific research aimed at further improving the safety and efficacy of veterinary drug residues and additives (7).
In conclusion, Sulfonamides Residue (SAs) in veterinary drug residues and additives is a crucial aspect of ensuring the safety of animal-derived products, regulatory compliance, and addressing antibiotic resistance. Precise measurement techniques, facilitated by our advanced solutions, are integral to these efforts, ultimately benefitting both animal and human health.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.